Smartphone-delivered digital cognitive behavioral therapy (DCBT) demonstrates large effect size reductions in generalized anxiety disorder (GAD) symptom severity at 10 and 24 weeks post-intervention.
DCBT achieves significantly higher remission rates versus psychoeducation controls, with odds ratios exceeding 3 at 24 weeks, signaling durable clinical benefits.
The digital format overcomes traditional barriers including limited therapist availability and geographic constraints, enabling scalable dissemination of empirically supported CBT.
Complementary evidence from digital CBT for insomnia supports the broader potential of fully automated, patient-directed digital therapeutics to address common mental health conditions sustainably.
Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
